Oral disease-modifying therapies for relapsing-remitting multiple sclerosis. Thomas R H, Wakefield RA Am J Health Syst Pharm. 2015 Jan 1; 72(1):25-38. PMID: 25511835. Abstract CommentRecommendBookmarkWatch